BioSpace News Archive

Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, announced that the Company’s management will present its platform technology and discuss potential utility of RNAi therapeutics at two conferences in November 2019.

Vyaire Medical, Inc.'s bellavista 1000e ventilator has been granted 510 clearance from the U.S. Food and Drug Administration It is the newest addition to Vyaire’s high-end ventilation portfolio offering a comprehensive solution for hospitals with the integration of high flow oxygen therapy and advanced synchrony support for neonatal to adult patients in a single device.

Non-IND clinical study initiated to assess safety, tolerability and blood physiology; first subjects with sickle cell disease enrolled

Promega Corporation announced it has entered into a global collaboration with Merck, known as MSD outside the United States and Canada, to develop Promega’s microsatellite instability technology as an on-label, solid tumor companion diagnostic for use with Merck’s anti-PD-1 therapy, KEYTRUDA® The global collaboration will initially seek regulatory approval for the Promega MSI CDx in the United States and China.

First Monthly Walgreens Flu Index for October 2019 Shows Louisiana and Nevada Leading Texas on the State List for Flu Activity

UroGen Pharma Ltd. announced that it will report third quarter 2019 financial results on Tuesday, November 12, 2019, prior to the open of the market.

Abacus Health Products, Inc. announced that it will participate in the 2nd Annual Boston Cannabis Conference presented by Cowen.

Vela Diagnostics’ Sentosa® SQ HIV-1 Genotyping Assay is the first FDA De Novo designated Next Generation Sequencing (NGS) assay for detecting HIV-1 drug resistance mutations (DRMs).

Technavio has announced its latest market research report titled global knee replacement market 2020-2024.

Predictive Oncology (NASDAQ: POAI) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company for private and public entities.